| Efficacy of Upadacitinib Re-induction Therapy in Patients With Ulcerative Colitis Who Lost Response to 30 mg Maintenance Dose (NCT07700446) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2026-11-15 |
| Characterization of Colorectal Dysplasic Lesions and Stratification of Their Evolving Risk in Inflammatory Bowel Disease Patients: a Prospective, Observational and Multicenter Study (NCT07719426) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2026-09-15 |
| Optimal Care With Guselkumab in Crohn's Disease / OPTIM Study A Prospective Open Label Interventional, Multicenter Study (NCT07616687) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2026-06-18 |
| Efficacy of MIrikizumab to Achieve Transmural Healing in patiENTs With Crohn's Disease (NCT07292012) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2026-05-11 |
| Evaluation of a Remote Monitoring Application in the Follow-up of Patients With Active Inflammatory Bowel Diseases (NCT06742385) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2025-09-18 |
| Identification of Factors ASsociaTed With a Delayed Diagnosis in Crohn's Disease (NCT06250361) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2024-02-15 |
| Ibd CAncer and seRious Infections in France (I-CARE 2) (NCT06089590) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2024-01-25 |
| TRansmural hEaliNg Definition in CroHn's Disease (TRENCH 1) (NCT05903066) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2023-09-28 |
| VeDOlizumab PERsistence in IBD Patients After Switching From Intravenous to Subcutaneous Administration : a Real-life Multicenter Study (DOPER) (NCT05158517) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2022-03-20 |
| Management of Moderate POstoperative Recurrence in Crohn's Disease: a randoMizEd contROLled Trial of Therapeutic Escalation, the POMEROL Trial. (POMEROL) (NCT05072782) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2021-12-21 |
| A 24-month Real Life PErsistence Efficacy and Safety Study in IBD Patients in REMission Switched From Intravenous Infliximab to Subcutaneous Infliximab CT-P13 Remsima®SC (NCT04990258) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2021-09-06 |
| USTekinumab in Fistulising Perianal Crohn's Disease (USTAP) (NCT04496063) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2020-11-16 |
| A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab (NCT04183608) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2020-01-14 |
| Is the Endoscopic Remission Evaluation, Using the CREDO 1 Index / Score in CD Patients in Clinical Remission at Baseline, Predictive of Sustained Clinical Remission Using a 2-year Follow up (NCT03487900) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2018-03-13 |
| Crohn's Disease Endoscopic REmission Definition in an Objective Way (NCT03498625) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2018-03-13 |
| A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe Colitis (NCT02425852) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2016-12-01 |
| Intensive Treatment to Reach the Target With Golimumab in ulcErative coliTis - In-TARGET (NCT02425865) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2016-12-01 |
| IBD Cancer and Serious Infection in Europe (NCT02377258) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2016-03-04 |
| Evaluation of Digestive Damage and Associated Predictive Factors in Crohn's Disease 5 to 10 Years After Diagnosis (NCT02549976) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2015-12-01 |
| A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy (NCT02177071) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2015-10-09 |
| Changing the coUrse of cRohn's Disease With an Early Use of Adalimumab (NCT03306446) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2015-03-17 |
| Role of Capsule Endoscopy in the Evaluation of Mucosal Changes During Treatment of Patients With Active Crohn's Disease (NCT02193802) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2014-05-01 |
| Predictive Factors of ANTI-TNF Response in Luminal Crohn's Disease Complicated by Abscess (NCT02856763) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2013-04-01 |
| Study Investigating Tailored Treatment With Infliximab for Active Crohn's Disease (NCT01442025) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2012-06-01 |
| A Study Evaluating the Impact of an Educational Program (EDU-MICI) on Patients With Inflammatory Bowel Disease (NCT02550158) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2011-06-01 |
| Comparison of Ferrisat vs Placebo in Anemia Associated to Inflammatory Bowel Disease During Anti-TNF Therapy (NCT01428843) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2011-01-01 |
| CE-U and MRE to Predict the Efficacy of Anti-TNF Therapy in Crohn's Disease (NCT01183403) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2010-01-01 |
| Endoscopic Detection of Dysplasia in Crohn 's Disease Patient (NCT01180452) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2010-01-01 |
| Evaluation of the Applicability of the CDEIS to Data Obtained by the Colonic Capsule Endoscopy in Crohn Disease (NCT01183845) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2009-04-01 |
| Study Comparing Cyclosporine With Infliximab in Steroid-refractory Severe Attacks of Ulcerative Colitis (NCT00542152) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2007-06-01 |
| Endoscopic Severity Score of Small Bowel Crohn's Disease With Wireless Capsule Endoscopy (NCT00492791) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2007-03-01 |
| Stop Infliximab in Patients With Crohn's Disease (NCT00571337) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2005-12-01 |
| Early Immunosuppressants in Crohn's Disease (NCT00546546) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2005-07-01 |
| Fibrin Glue for Perianal Fistulas in Crohn's Disease: a Randomized Controlled Trial (NCT00723047) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2003-11-01 |
| Comparison Azathioprine to Mesalazine for the Prevention of Postoperative Recurrence in the Crohn Disease (NCT00976690) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2002-10-01 |